1. Academic Validation
  2. Antiopioid properties of the TYR-MIF-1 family

Antiopioid properties of the TYR-MIF-1 family

  • Methods Find Exp Clin Pharmacol. 2004 Nov;26(9):673-7. doi: 10.1358/mf.2004.26.9.872564.
A Bocheva 1 E Dzambazova-Maximova
Affiliations

Affiliation

  • 1 Institute of Physiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., bl. 23, 1113 Sofia, Bulgaria. bocheva@bio.bas.bg
Abstract

The Tyr-MIF-1 family of Peptides includes MIF-1, Tyr-MIF-1, Tyr-W-MIF-1 and Tyr-K-MIF-1, which have been isolated from bovine hypothalamus and human brain cortex. All these Peptides interact with opioid receptors and in addition bind to non-opiate sites specific for each of the Peptides. Data in the literature suggest that Peptides of the Tyr-MIF-1 family (Tyr-MIF-1s) have antiopioid and opioid- like effects. It is known that some anti-opioid Peptides (AOP) could reverse morphine-induced analgesia in rodents and men and able to inhibit the expression of some forms of stress-induced analgesia (SIA) in various species. We examined the effects of the Tyr-MIF-1 Peptides (all in dose 1 mg/kg i.p.) in the male Wistar rats on morphine-induced analgesia in acute pain using the paw-pressure (PP) and the tail-flick (TF) tests and on immobilization stress-induced antinociception using the PP test. Our results showed that the Tyr-MIF-1 Peptides significantly decreased the analgesic effect of morphine (1 mg/kg i.p.) in both tests used. Immobilization of the rats increased the pain threshold for at least 1 h. The Tyr-MIF-1 Peptides reduced stress-induced antinociception in PP test. In conclusion, our findings indicate that Tyr-MIF-1s modulate the analgesic effects of morphine and SIA, which corresponds with the hypothesis about AOP mentioned above.

Figures
Products